Cannabis Remains Schedule I Federally Despite 38-State Patchwork

Federal Schedule I Classification Unchanged

Cannabis retains its Schedule I designation under 21 U.S.C. §812, meaning federal law recognizes no accepted medical use and high abuse potential. The Drug Enforcement Administration hasn't moved cannabis to a lower schedule despite multiple petitions and executive directives. On a strict reading of the Controlled Substances Act, cultivation, distribution, and possession remain federal felonies punishable by up to five years for first-time offenses under 21 U.S.C. §844.

The Biden administration initiated a rescheduling review in 2022, but the process stalled in administrative proceedings. As of May 25, 2026, no final rule has been published in the Federal Register.

State-Legal Markets Operate in Federal Gray Zone

Thirty-eight states have enacted medical or adult-use cannabis laws, creating a regulatory framework that conflicts directly with federal prohibition. State programs license cultivation, processing, retail, and testing operations that would otherwise violate the CSA. Licensed operators face:

• Criminal exposure under 21 U.S.C. §841 (manufacturing) and §846 (conspiracy)
• Asset forfeiture risk under 21 U.S.C. §881
• Denial of federal bankruptcy protection under 11 U.S.C. §109
• Interstate commerce restrictions under the dormant Commerce Clause

Since the 2013 Cole Memorandum, the Department of Justice has maintained prosecutorial discretion policies. But these policies are non-binding guidance. Any administration can reverse them.

IRC §280E Denies Ordinary Business Deductions

Internal Revenue Code §280E prohibits cannabis operators from deducting ordinary business expenses because the substance remains federally illegal. The statute disallows deductions for any trade or business trafficking in Schedule I or II controlled substances, limiting operators to cost-of-goods-sold deductions under Treas. Reg. §1.471-3. Effective tax rates for plant-touching businesses often exceed 70 percent of gross profit.

State-legal operators must file federal tax returns reporting revenue from federally illegal activity. The IRS has issued no safe harbor guidance. Tax Court precedent in Olive v. Commissioner, 139 T.C. 19 (2012), and Alterman v. Commissioner, T.C. Memo 2018-83, affirms that state legality doesn't override §280E.

Banking Access Remains Restricted Under BSA

Federal banking regulations treat cannabis revenue as proceeds of illegal activity, forcing most operators into cash-intensive models. The Bank Secrecy Act requires financial institutions to file Suspicious Activity Reports for transactions involving Schedule I substances. FinCEN's 2014 guidance permits banks to serve cannabis clients under strict due-diligence protocols, but fewer than 800 of 4,800 U.S. banks participate as of 2026.

The SAFE Banking Act has passed the House seven times since 2019. It hasn't advanced in the Senate. Without statutory protection, banks face potential prosecution under 18 U.S.C. §1956 (money laundering) and §1957 (monetary transactions in criminal proceeds).

Interstate Commerce Prohibited by Dormant Clause

Cannabis can't cross state lines even between legal jurisdictions because federal prohibition renders interstate transport a felony under 21 U.S.C. §841(a)(1). Each state program operates as a closed-loop system. The dormant Commerce Clause, which normally prevents states from discriminating against out-of-state commerce, doesn't apply to transactions involving contraband under Alliance of Automobile Manufacturers v. Gwadosky, 430 F.3d 30 (1st Cir. 2005).

Multi-state operators must establish separate cultivation and processing facilities in each state, duplicating capital expenditures and supply-chain infrastructure. No federal framework exists to harmonize state regulations or permit cross-border wholesale transactions.

Federal Employees and Contractors Face Termination Risk

Federal workplace drug policies prohibit cannabis use regardless of state law, subjecting employees and contractors to termination for positive tests. The Drug-Free Workplace Act of 1988 requires federal contractors to maintain drug-free policies. OPM issued guidance in 2021 clarifying that state-legal use doesn't constitute a defense to adverse employment actions.

Security clearance applicants must disclose cannabis use on Standard Form 86. Adjudicators consider recency and context, but any use within 12 months typically triggers a denial under adjudicative guidelines for drug involvement.

Legislative Path Forward Remains Uncertain

Federal legalization or rescheduling would require either congressional action via the MORE Act or CAOA, or DEA rulemaking under the Administrative Procedure Act. The Marijuana Opportunity Reinvestment and Expungement Act and the Cannabis Administration and Opportunity Act have both stalled in committee. Rescheduling to Schedule III would preserve some §280E penalties and maintain federal oversight.

For comprehensive analysis of federal cannabis policy developments, see the CannIntel topic hub on federal cannabis legalization. The next legislative window opens with the 119th Congress in January 2027, but passage remains contingent on Senate floor dynamics and executive-branch priorities.